Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
Authors:
- Leah M PrenticeLPLeah M Prentice
- Christian KlausenCKChristian Klausen
- Steve KallogerSKSteve Kalloger
- Martin KöbelMKMartin Köbel
- Steven McKinneySMSteven McKinney
- Jennifer L SantosJSJennifer L Santos
- Challayne KenneyCKChallayne Kenney
- Erika MehlEMErika Mehl
- C B GilksCGC B Gilks
- Peter LeungPLPeter Leung
- Ken SwenertonKSKen Swenerton
- David G HuntsmanDHDavid G Huntsman